Tamsulosin + Finasteride + Placebo

ApprovedUNKNOWN
0 watching 0 views this week๐Ÿ”ฅ Hot
85
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Benign Prostate Hyperplasia

Conditions

Benign Prostate Hyperplasia

Trial Timeline

Feb 1, 2012 โ†’ Jun 1, 2017

About Tamsulosin + Finasteride + Placebo

Tamsulosin + Finasteride + Placebo is a approved stage product being developed by Astellas Pharma for Benign Prostate Hyperplasia. The current trial status is unknown. This product is registered under clinical trial identifier NCT01736033. Target conditions include Benign Prostate Hyperplasia.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01736033ApprovedUNKNOWN

Competing Products

20 competing products in Benign Prostate Hyperplasia

See all competitors